We make mRNA vaccines and therapies.
BASE Facility is at the forefront of biotechnology research, specializing in the manufacture and research of mRNA vaccines and therapies. With comprehensive end-to-end capabilities, BASE Facility excels in the design, manufacture, and formulation of mRNAs, positioning itself as a leading supplier in the field.
Located at Cnr College Rd & Cooper Rd, St Lucia, Level 3, AIBN (Building 75), Brisbane, Queensland 4072, AU, BASE Facility is driven by a team of expert scientists who bring extensive experience to the development of mRNA drugs for a diverse range of applications. Additionally, BASE Facility also operates from 37 Kent St, Level 6, TRI, Woolloongabba, Queensland 4102, AU.
BASE Facility is also committed to advancing the science of mRNA through its robust research program focused on drug discovery and development. With a dedication to understanding mechanisms of action and creating innovative mRNA therapies, BASE Facility is set to make significant contributions to the biotechnology landscape. We invite the management of BASE Facility to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and commercial opportunities.
BASE Facility est à l'avant-garde de la recherche biotechnologique, spécialisée dans la fabrication et la recherche de vaccins et de thérapies à ARNm. Grâce à des capacités complètes de bout en bout, BASE Facility excelle dans la conception, la fabrication et la formulation d'ARNm, se positionnant comme un fournisseur de premier plan dans le domaine.
Situé à Cnr College Rd & Cooper Rd, St Lucia, Level 3, AIBN (Building 75), Brisbane, Queensland 4072, AU, BASE Facility est animé par une équipe de scientifiques experts qui apportent une vaste expérience au développement de médicaments à ARNm pour un large éventail d'applications. De plus, BASE Facility opère également depuis le 37 Kent St, Level 6, TRI, Woolloongabba, Queensland 4102, AU.
BASE Facility s'engage également à faire progresser la science de l'ARNm grâce à son solide programme de recherche axé sur la découverte et le développement de médicaments. Avec un dévouement à la compréhension des mécanismes d'action et à la création de thérapies ARNm innovantes, BASE Facility est sur le point d'apporter des contributions significatives au paysage biotechnologique. Nous invitons la direction de BASE Facility à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore votre visibilité et vos opportunités commerciales.
Compare BASE Facility with 3 companies in Biotechnology-Research
| Comparison Field |
BASE FacilityMain Company |
Digitas UKView Profile |
Maravai LifeSciencesView Profile |
A*STAR Genome Instit...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2006 | 2014 | 2000 |
|
Company Size
|
— | 501-1,000 | 501-1,000 | 201-500 |
|
City
|
Brisbane, Queensland | London, London | San Diego, California | |
|
Country
|
Australia | United Kingdom | United States | |
|
Skills & Keywords
Comparing with main company
|
22 Total Skills
mRNA vaccines
mRNA therapies
Biotechnology Research
mRNA Manufacturing
Drug Discovery
Pharmaceutical Development
Synthetic Biology
biomanufacture
DNA
Nucleic Acids
Biotechnology
RNA
university
vaccines
therapies
Bioprocess
Research
manufacturing
Analytics
development
pharmacy
mRNA
|
46 Total
46 Unique
Unique Skills:
3D Design / Animation
A/B testing
AI
App / Cloud / Content / GMP Opps
applications
AR/VR
+40
|
16 Total
16 Unique
Unique Skills:
Bioprocess Impurity Detection
CDMO Services
Custom Chemistry
Enzymes
Gene Therapy
Genomics
+10
|
8 Total
8 Unique
Unique Skills:
Cancer Stem Cell Biology
Cancer Therapeutics & Stratified Oncology
Computational & Systems Biology
Genomic Technologies
Human Genetics
Infectious Diseases
+2
|
Other organizations in the same industry
This company is also known as